Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study. J. Trop. Pharm. Chem. 2021;5(4):347-352. doi:10.30872/j.trop.pharm.chem.v5i4.257